Stay updated on Derazantinib in Advanced Cholangiocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.5%
    Check dated 2025-05-07T16:55:32.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.5%
    Check dated 2025-04-30T06:27:10.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-04-22T23:53:04.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has removed detailed descriptions of a Phase II study on derazantinib for intrahepatic cholangiocarcinoma, including key inclusion and exclusion criteria, while adding a new identifier and a revision number.
    Difference
    35%
    Check dated 2025-04-15T20:39:48.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4, and a previously available item is now marked as no longer available.
    Difference
    0.5%
    Check dated 2025-04-08T17:09:46.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.4%
    Check dated 2025-04-01T13:26:00.000Z thumbnail image

Stay in the know with updates to Derazantinib in Advanced Cholangiocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.